Eric di Luccio
Has grant
Executive officer / Chief Technology Officer (CTO)
Research Interests
Explore related searches
Contact this professor
About
Eric di Luccio is the Executive Officer and Chief Technology Officer (CTO) at Hirotsu Bio Science in Japan. His research focuses on innovative cancer diagnostics, particularly utilizing machine learning frameworks, molecular integration, and non-invasive detection techniques. He has published extensively on topics such as tumor detection through volatile organic compounds and advancements in veterinary oncology. His recent work emphasizes the integration of computational sciences in enhancing early cancer detection and treatment responses.
Recent Grants
Grant: Close
Role of Set7 in Schizosaccharomyces pombe gametogenesis Implication in human infertility
Open Date: 2018-06-01
Close Date: 2022-02-01
Grant: Close
Static and dynamic crystal lographic investigations for developing specific and selective inhibitors for the epigenetic therapy of cancers
Open Date: 2016-02-01
Close Date: 2017-12-01
Grant: Close
Structural Biology of oncogenic HMTases
Open Date: 2014-05-01
Close Date: 2017-05-01
Grant: Close
LEM-07, inhibitor of NSD2/MMMSET
Open Date: 2014-03-01
Close Date: 2015-01-01
Grant: Close
LEM-07, inhibitor of NSD2/MMMSET
Open Date: 2014-01-01
Close Date: 2015-01-01
Articles (20)
Year:
2025
Collaborators (7)
Taroh Satoh
Osaka University Hospital
Yoshihisa Tokumaru
Assistant professor
Gifu University Graduate School of Medicine
Takuma Ishihara
Gifu University
Hidetoshi Eguchi
-
Andrea Vecchione
-
Hideshi Ishii
-
shingen nakamura
Tokushima University
How do I reach out?
Sign in for free to see their profile details and contact information.